Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,512.38 -3.89 -0.03%
TOPIX 1,171.40 -1.97 -0.17%
HANG SENG 22,760.24 64.23 0.28%

Safeguard Scientifics Names Jeffrey B. McGroarty Senior Vice President and Chief Financial Officer



  Safeguard Scientifics Names Jeffrey B. McGroarty Senior Vice President and
  Chief Financial Officer

Business Wire

WAYNE, Pa. -- April 25, 2013

Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in
growth-stage healthcare and technology companies, announced that Jeffrey B.
McGroarty, 43, an accounting and financial executive who joined the Company in
2005 as Vice President and Corporate Controller, was named Senior Vice
President and Chief Financial Officer, effective today. Mr. McGroarty succeeds
Stephen T. Zarrilli, 51, who was named President and Chief Executive Officer
of Safeguard on November 1, 2012.

Jeffrey B. McGroarty, Senior Vice President and Chief Financial Officer
(Photo: Business Wire)

Jeffrey B. McGroarty, Senior Vice President and Chief Financial Officer
(Photo: Business Wire)

“Jeff is a strong, capable executive who has worked closely with me to improve
Safeguard’s financial strength and flexibility, positioning the Company to
maximize value,” said Mr. Zarrilli.

During his tenure at Safeguard, Mr. McGroarty has managed the Company’s
accounting, financial operations, SEC reporting, treasury and tax functions,
and also has delivered value-added guidance and service in these same areas to
Safeguard’s partner companies.

“I’m energized by this opportunity to further sharpen Safeguard’s focus on its
core business, increase capital under management and continue to build
high-potential, growth-stage companies in the healthcare and technology
sectors as we work towards more consistent monetizations,” said Mr. McGroarty.

Prior to joining Safeguard in December 2005, Mr. McGroarty was interim
Controller at Cephalon, Inc. (NASDAQ: CEPH), an international
biopharmaceutical company. Before that, he was Vice President, Financial
Planning and Analysis at Exide Technologies (NASDAQ:XIDE), a global
manufacturer and recycler of lead-acid batteries. While at Exide, Mr.
McGroarty had a major role in the company’s reorganization and emergence from
bankruptcy. He began his career at PricewaterhouseCoopers LLP, where he was
responsible for domestic and international audits, due diligence, consulting
and post-transaction integration of mergers and acquisitions for clients in
the U.S. and United Kingdom.

Mr. McGroarty earned a B.A. degree in accounting from Pennsylvania State
University and has M.B.A. degree from The Wharton School of the University of
Pennsylvania.

About Safeguard Scientifics

Founded in 1953 and based in Wayne, Pa., Safeguard Scientifics, Inc.
(NYSE:SFE) provides growth capital and operational support to entrepreneurial
and innovative healthcare and technology companies in medtech, healthtech,
specialty pharmaceuticals, financial technology, digital media, and Enterprise
3.0. For more information, please visit our website at www.safeguard.com.

Safeguard Press Resources

Blog: blog.safeguard.com
Twitter: @Safeguard
StockTwits: SFE
LinkedIn: Safeguard Scientifics
YouTube: SafeguardSFE
SlideShare: SafeguardScientifics

Forward-looking Statements

Except for the historical information and discussions contained herein,
statements contained in this release may constitute "forward-looking
statements" within the meaning of the Private Securities Litigation Reform Act
of 1995. Our forward-looking statements are subject to risks and
uncertainties. The risks and uncertainties that could cause actual results to
differ materially include, among others, managing rapidly changing
technologies, limited access to capital, competition, the ability to attract
and retain qualified employees, the ability to execute our strategy, the
uncertainty of the future performance of our companies, acquisitions and
dispositions of companies, the inability to manage growth, compliance with
government regulations and legal liabilities, additional financing
requirements, the effect of economic conditions in the business sectors in
which our companies operate, and other uncertainties described in the
Company's filings with the Securities and Exchange Commission. Many of these
factors are beyond our ability to predict or control. As a result of these and
other factors, our past financial performance should not be relied on as an
indication of future performance. The Company does not assume any obligation
to update any forward-looking statements or other information contained in
this news release.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130425005316/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50618013&lang=en

Contact:

Safeguard Scientifics, Inc.
John E. Shave III
Vice President, Business Development
and Corporate Communications
610-975-4952
jshave@safeguard.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement